Compare SRRK & ATMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | ATMU |
|---|---|---|
| Founded | 2012 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.0B |
| IPO Year | 2018 | 2023 |
| Metric | SRRK | ATMU |
|---|---|---|
| Price | $44.36 | $49.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | $56.17 | ★ $58.25 |
| AVG Volume (30 Days) | ★ 1.0M | 811.3K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | N/A | ★ 12.61 |
| EPS | N/A | ★ 0.59 |
| Revenue | N/A | ★ $1,764,300,000.00 |
| Revenue This Year | N/A | $15.00 |
| Revenue Next Year | $534.24 | $5.13 |
| P/E Ratio | ★ N/A | $84.41 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $27.07 | $34.58 |
| 52 Week High | $52.19 | $66.50 |
| Indicator | SRRK | ATMU |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 49.59 |
| Support Level | $42.52 | $44.06 |
| Resistance Level | $48.23 | $51.16 |
| Average True Range (ATR) | 2.10 | 1.57 |
| MACD | -0.36 | 0.58 |
| Stochastic Oscillator | 14.24 | 93.30 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. The company designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. It designs, manufactures, and sells filters, coolants, and chemical products. The company offers products including air filtration, coolants and chemicals, crankcase ventilation, fuel filtration, fuel cells, lube filtration, and others.